- Home
- CSIQ vs PHAR Comparison
CSIQ vs PHAR Comparison
Compare CSIQ & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSIQ
- PHAR
- Stock Information
- Founded
- CSIQ 2001
- PHAR 1988
- Country
- CSIQ Canada
- PHAR Netherlands
- Employees
- CSIQ N/A
- PHAR N/A
- Industry
- CSIQ Semiconductors
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- CSIQ Technology
- PHAR Health Care
- Exchange
- CSIQ Nasdaq
- PHAR Nasdaq
- Market Cap
- CSIQ 732.6M
- PHAR 587.5M
- IPO Year
- CSIQ 2006
- PHAR N/A
- Fundamental
- Price
- CSIQ $8.66
- PHAR $7.90
- Analyst Decision
- CSIQ Hold
- PHAR Strong Buy
- Analyst Count
- CSIQ 10
- PHAR 3
- Target Price
- CSIQ $17.84
- PHAR $30.00
- AVG Volume (30 Days)
- CSIQ 1.8M
- PHAR 6.7K
- Earning Date
- CSIQ 03-25-2025
- PHAR 03-13-2025
- Dividend Yield
- CSIQ N/A
- PHAR N/A
- EPS Growth
- CSIQ N/A
- PHAR N/A
- EPS
- CSIQ 0.54
- PHAR N/A
- Revenue
- CSIQ $5,993,409,000.00
- PHAR $297,200,000.00
- Revenue This Year
- CSIQ $25.52
- PHAR $8.26
- Revenue Next Year
- CSIQ $15.71
- PHAR $9.73
- P/E Ratio
- CSIQ $16.02
- PHAR N/A
- Revenue Growth
- CSIQ N/A
- PHAR 21.15
- 52 Week Low
- CSIQ $8.34
- PHAR $6.65
- 52 Week High
- CSIQ $21.05
- PHAR $11.30
- Technical
- Relative Strength Index (RSI)
- CSIQ 35.51
- PHAR 38.11
- Support Level
- CSIQ $8.34
- PHAR $8.03
- Resistance Level
- CSIQ $10.57
- PHAR $8.70
- Average True Range (ATR)
- CSIQ 0.58
- PHAR 0.29
- MACD
- CSIQ -0.11
- PHAR -0.05
- Stochastic Oscillator
- CSIQ 14.11
- PHAR 0.00
About CSIQ Canadian Solar Inc. (ON)
Canadian Solar Inc is a Canadian solar power company. It is an integrated provider of solar power products, services, and system solutions. The company engages in designing, developing, and manufacturing solar ingots, wafers, cells, modules, and other solar power products. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. Its Recurrent segment primarily comprises solar and battery storage project development and sale, O&M and asset management services for operational projects, sale of electricity, and investment in retained assets.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.